Alnylam Pipeline: Fitusiran and Inclisiran

(2:4)

Insights into the mechanism of action of fitusiran \u0026 the value of this agent in hemophilia treatment

(3:3)

Hemophilia A and B, new Phase II data confirming fitusiran and RNA interference technology

(3:31)

The promise of fitusiran for the treatment of patients with hemophilia A and B

(1:48)

Fitusiran and Hemophilia: Early Data Very Promising

(3:31)

Fitusiran Overview with Dr. Guy Young

(54:50)

The safety and efficacy of fitusiran prophylaxis in patients with hemophilia A and B

(1:43)

Guy Young: Fitusiran for Hemophilia A and B With Inhibitors

(7:56)

Fitusiran prophylaxis shows encouraging results in hemophilia patients

(3:29)

A Fitusiran Clinical Trial Update and Nikole Scappe Co-Wrote A Book!

(24:47)

Fitusiran significantly reduces bleeding events in patients with hemophilia A or B, with inhibitors

(3:4)

Promising therapeutic options emerging in hemophilia

(39)

See Hemophilia Through My Eyes: Relationships

(3:14)

How hemophilia care has changed over the years

(1:58)

ISTH Academy Presentation: New Treatments in Hemophilia

(27:14)

Understanding Hemophilia

(1:34)

The Future of Nonfactor Therapies in Hemophilia A and B: The Art and Science of RNA Interference

(23:49)

CDC Webinar: New Opportunities and Challenges in Hemophilia Care

(58:44)

An overview of ongoing clinical trials for the treatment of hemophilia

(2:8)